News: Pfizer's Read Justifies Cuts and Closures

So what’s Pfizer’s new chief executive like? Tough, unapologetic, and obsessed with accountability. At a meeting with reporters yesterday after the company announced that it would cut thousands of research jobs in order to maintain its 2012 earnings per share forecasts, Ian Read argued that cutting the R&D budget could actually improve Pfizer’s research prospects.
Feb. 3, 2011
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates